The CGRP Pathway in Migraine as a Viable Target for Therapies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The CGRP Pathway in Migraine as a Viable Target for Therapies.
- Published In:
- Headache, 58 Suppl 1, 33-47 (2018)
- Authors:
- Edvinsson, Lars(6)
- Database ID:
- RPEP-03658
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03658APA
Edvinsson, Lars. (2018). The CGRP Pathway in Migraine as a Viable Target for Therapies.. Headache, 58 Suppl 1, 33-47. https://doi.org/10.1111/head.13305
MLA
Edvinsson, Lars. "The CGRP Pathway in Migraine as a Viable Target for Therapies.." Headache, 2018. https://doi.org/10.1111/head.13305
RethinkPeptides
RethinkPeptides Research Database. "The CGRP Pathway in Migraine as a Viable Target for Therapie..." RPEP-03658. Retrieved from https://rethinkpeptides.com/research/edvinsson-2018-the-cgrp-pathway-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.